67184-0535-1 : NDC 2026 Code

67184-0535-1 : Decitabine ( Decitabine )

Additionally :

You can get information about “67184-0535-1” NDC code in 67184-0535-1 in HTML format

HTML | 67184-0535-1 in TXT (Plain Text) format

TXT | 67184-0535-1 in PDF (Portable Document Format)

PDF | 67184-0535-1 in XML format

XML formats.

NDC Code : 67184-0535-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "67184-0535-1",
    "PackageDescription": "1 VIAL in 1 CARTON (67184-0535-1)  &gt; 20 mL in 1 VIAL",
    "NDC11Code": "67184-0535-01",
    "ProductNDC": "67184-0535",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Decitabine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Decitabine",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20210412",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212826",
    "LabelerName": "Qilu Pharmaceutical Co., Ltd.",
    "SubstanceName": "DECITABINE",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/20mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2021-10-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210412",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}